LIFTING OF MAXILLARY SINUS WITH BONE MORPHOGENETIC PROTEIN 2: SYSTEMATIC REVIEW

Karen de Lima Rodrigues, Lara Cristina Mesquita de Morais, Marta Rosado de Oliveira Campos, Eduardo Souza de Lobão Veras, José Pereira de Melo Neto

Resumo


Objectives: To analyze the capacity of bone neoformation after maxillary sinus lift with rhBMP-2 and its effects, compared to other concentrations and grafts. Materials and Methods: Followed Cochrane guidelines and the databases used for research articles were PubMed, BVS, CENTRAL Cochrane Library and Scopus. Results: 4 articles were selected. From the studies on bone density reported that the rhBMP-2 group presented inferior results to the control group, nevertheless, after installation of load this group increased considerably. With analysis of the vertical bone augmentation they found similar results between the groups. All articles reported adverse events presenting similar results in relation to rhBMP-2. Conclusion: The RhBMP-2 obtained good bone neoformation after the application of functional load and adequate vertical bone quantity for dental implant rehabilitation. In addition, higher concentrations induce bone formation more quickly, but with more adverse effects. 
Descriptors: Bone Morphogenetic Protein 2; Maxillary Sinus; Sinus Augmentation.


Palavras-chave


Descritores: Proteína morfogenética óssea 2, Seio Maxilar, Aumento de seio

Texto completo:

PDF

Referências


Bezerra FJB, Lenharo A. Terapia clínica avançada em implantodontia. São Paulo: Artes Médicas, 2002.

Jayme S, Abutara FH. Princípios da enxertia em seio maxilar: revisão de literatura. Rev. bras. implantodont. Protese implant. 2003; 10(40):351-5.

Gonçalves ARQ. A associação do plasma rico em plaquetas com o osso bovino inorgânico, em enxertos de seio maxilar, induz a neoformação óssea? [Monografia]. Rio de Janeiro: Ciodonto.2008; 1-78.

Filho M, Teixeira ALM, Araújo ERL, Santos KS, Leal IMSP, Sousa N. Seio maxilar e sua relação de proximidade com as raízes dos dentes superiores posteriores: uma revisão bibliográfica. Revista Univap. 2006; 13(24):1929-32.

Abadzhiev M. Alternative Sinus Lift Techiniques: literature Review. Journal of IMAB. 2009; 9(2):23-7.

Esposito M, Grusovin MG, Polyzos IP, Felice P, Worthington HV. Interventions for replacing missing teeth: dental implants in fresh extraction sockets (immediate, immediatedelayed and delayed implants). Cochrane Database Syst Rev. 2010;8:9-12.

Urist MR. Bone: formation by autoindution. Science. 1965; 150: 893-9.

Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res. 1971; 50:1392-406.

Sakou T. Bone morphogenetic proteins: From basic studies to clinical approaches. Bone. 1998; 22:591–603.

Wozney JM. The bone morphogenetic protein family and osteogenesis. Molecular Reproduction and Development. New York. 1992; 32(2):160-167.

Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg. 1991; 117(10):1101-12.

Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP et al. Purification and characterization of other distinct bone-inducing factors. Proc. Natl. Acad. Sci. U.S.A. 1988; 85; 9484-9488.

Zétola A, Pereira LAV. Proteína Óssea Morfogenética: do básico à aplicabilidade clínica. Implantodontia Baseada em Evidência Científica: ABROSS 2010 – IX Encontro Internacional da Academia Clínica Brasileira de Osseointegração. São Paulo: Quintessence. 2010; 285-297.

Spagnoli DB, Santos SE, Moreira RWF. A utilização da proteína óssea recombinante humana nas reconstruções ósseas. Enxertos ósseos em Implantodontia. São Paulo: Napoleão. 2012:436-69.

Lee JH, KIM CS, Choi KH, Jung UW, Yun JH, Choi SH, et al. A indução de formação óssea em defeitos de calvária de ratos e tecidos subcutâneos por BMP-2 humana recombinante, produzida em Escherichia coli. Biomaterials 2010; 31:3512–3519.

Long S, Truong L, Bennett K, Phillips A, Wong-Staal F, Ma H. Expressão, purificação e renaturação da proteína morfogenética óssea-2 de Escherichia coli. Protein Expr Purif. 2006; 46:374-378.

Cochran DL, Jonas AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol. 2000; 71(8):1241-57.

Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 2005; 76(4):605-13.

Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg. 2008; 66(7):1417-25.

Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg. 2005; 63(12):1693-707.

Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg. 2009; 67(9):1947-1960.

Kim MS, Lee JS, Shin HK, Kim JS, Yun JH, Cho KS. Prospective randomized, controlled trial of sinus grafting using Escherichia-coli-produced rhBMP-2 with a biphasic calcium phosphate carrier compared to deproteinized bovine bone. Clin Oral Implants Res. Sep, 2014.

Kim HJ, Chung JH, Shin SY, Shin SY, Kye SB, KIM NK, et al. Efficacy of rhBMP-2/Hydroxyapatite on Sinus Floor Augmentation: A Multicenter, Randomized Controlled Clinical Trial. J Dent Res. 2015; 94(9):158S-65S.

Alt V, Chhabra A, Bentley A, Eicher A, Schnettler R. A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France. 2009; 40(12):1269-75.

Kelly MP, Vaughn OI, Anderson PA. Systematic Review and Meta-Analysis of Recombinant Human Bone Morphogenetic Protein-2 in Localized Alveolar Ridge and Maxillary Sinus Augmentation. J Oral Maxillofac Surg. 2016; 74(5):928-39.

Tan Y, Montgomery SR, Aghdasi BG, Inoue H, Kaner T, Tian H, et al. The effect of corticosteroid administration on soft-tissue inflammation associated with rhBMP-2 use in a rodent model of inflammation. Spine (Phila Pa 1976). 2013; 38(10):806-13.




DOI: https://doi.org/10.35169/for.v2i3.46

Apontamentos

  • Não há apontamentos.


Direitos autorais 2020 Focus Oral Research